Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_assertion type Assertion NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_head.
- NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_assertion description "[G-CSF has also been applied in priming strategies designed to enhance the sensitivity of leukemia stem cells to cytotoxic agents, in protocols aimed to induce their differentiation and accompanying growth arrest and cell death, and in severe aplastic anemia and myelodysplastic syndrome (MDS) to alleviate anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_provenance.
- NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_assertion evidence source_evidence_literature NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_provenance.
- NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_assertion SIO_000772 20237318 NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_provenance.
- NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_assertion wasDerivedFrom befree-20140225 NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_provenance.
- NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_assertion wasGeneratedBy ECO_0000203 NP648171.RAFMtByNmQqcNPixQwR5kBKhq4nLr6QK7nkBU9vuBCSqg130_provenance.